1 |
15 or 45 mg |
- |
- |
- |
- |
067 1件: 67 💬 |
2 |
30 or 60 mg |
- |
- |
- |
- |
067 1件: 67 💬 |
3 |
30 or 90 mg |
- |
- |
- |
- |
067 1件: 67 💬 |
4 |
[metformina] |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
067 1件: 67 💬 |
5 |
[tol |
- |
- |
- |
- |
067 1件: 67 💬 |
6 |
[tolvaptan 15] |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
7 |
[tolvaptan 30] |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
8 |
[tolvaptan 45/15] |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
9 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
10 |
Al |
- |
- |
- |
- |
005 9件: 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
11 |
Amias |
- |
- |
- |
- |
067 1件: 67 💬 |
12 |
Aminohippurate |
Aminohippuric acid |
2件: D01421 D01421, D06890 D06890 💬 |
- |
- |
067 1件: 67 💬 |
13 |
Aminohippurate sodium inj 20% |
Aminohippuric acid |
2件: D01421 D01421, D06890 D06890 💬 |
- |
- |
067 1件: 67 💬 |
14 |
Amlodipine |
Amlodipine |
3件: D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 67, 298 💬 |
15 |
Anti-hypertensive medications |
- |
- |
- |
- |
067 1件: 67 💬 |
16 |
Antihypertensive drugs |
- |
- |
- |
- |
067 1件: 67 💬 |
17 |
Aprinox |
- |
- |
- |
- |
067 1件: 67 💬 |
18 |
Arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
046 9件: 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
19 |
Bardoxolone |
Bardoxolone |
1件: D09584 D09584 💬 |
- |
- |
066 7件: 66, 67, 84, 85, 86, 218, 222 💬 |
20 |
Bardoxolone methyl |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
066 7件: 66, 67, 84, 85, 86, 218, 222 💬 |
21 |
Bardoxolone methyl 10 mg |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
067 1件: 67 💬 |
22 |
Bardoxolone methyl 15 mg |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
067 1件: 67 💬 |
23 |
Bardoxolone methyl 20 mg |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
067 1件: 67 💬 |
24 |
Bardoxolone methyl 5 mg |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
067 1件: 67 💬 |
25 |
Bardoxolone methyl capsules |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
066 4件: 66, 67, 86, 222 💬 |
26 |
Bardoxolone methyl oral capsule |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
067 1件: 67 💬 |
27 |
Behavioral: diet and water adjustment |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
28 |
Bendroflumethiazide |
Bendroflumethiazide |
1件: D00650 D00650 💬 |
- |
- |
067 1件: 67 💬 |
29 |
Bim 23014 |
- |
- |
- |
- |
067 1件: 67 💬 |
30 |
Bisoprolol |
Bisoprolol |
2件: D00634 D00634, D02342 D02342 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 3件: 67, 86, 113 💬 |
31 |
Bosutinib |
Bosutinib |
1件: D03252 D03252 💬 |
ABL1 2件: ABL1, SRC 💬 |
Adherens junction 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
002 2件: 2 , 67 💬 |
32 |
Bosutinib (anhydrous) |
Bosutinib |
1件: D03252 D03252 💬 |
ABL1 2件: ABL1, SRC 💬 |
Adherens junction 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
067 1件: 67 💬 |
33 |
C03xa01 |
- |
- |
- |
- |
067 2件: 67, 72 💬 |
34 |
Calcineurin inhibitors maintenance |
- |
- |
- |
- |
067 1件: 67 💬 |
35 |
Candesartan |
Candesartan |
1件: D00522 D00522 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 2件: 58, 67 💬 |
36 |
Candesartan and cilnidipine |
Candesartan |
2件: D00522 D00522, D01173 D01173 💬 |
AGTR1 6件: AGTR1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
AGE-RAGE signaling pathway in diabetic complications 48件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Apelin signaling pathway, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Renin secretion, Renin-angiotensin system, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 1件: 67 💬 |
37 |
Candesartan plus non-ccb agents |
Candesartan |
1件: D00522 D00522 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
067 1件: 67 💬 |
38 |
Cardura |
- |
- |
- |
- |
067 1件: 67 💬 |
39 |
Certican |
- |
- |
- |
- |
067 4件: 67, 96, 158, 228 💬 |
40 |
Certican tabletten |
- |
- |
- |
- |
067 1件: 67 💬 |
41 |
Cilnidipine |
Cilnidipine |
1件: D01173 D01173 💬 |
CACNA1B 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 40件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Nicotine addiction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 1件: 67 💬 |
42 |
Conventional therapy |
- |
- |
- |
- |
067 2件: 67, 222 💬 |
43 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
44 |
Doxazosin |
Doxazosin |
2件: D00608 D00608, D07874 D07874 💬 |
ADRA1A 3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 2件: 57, 67 💬 |
45 |
Emodin |
Emodin |
- |
- |
- |
067 1件: 67 💬 |
46 |
Equal |
- |
- |
- |
- |
006 5件: 6 , 13, 67, 86, 230 💬 |
47 |
Everolimus |
Everolimus |
1件: D02714 D02714 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
034 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬 |
48 |
G1117337 |
- |
- |
- |
- |
067 2件: 67, 299 💬 |
49 |
Genz-682452 |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
006 3件: 6 , 19, 67 💬 |
50 |
Genz-682452-au |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
006 3件: 6 , 19, 67 💬 |
51 |
Glpg2737 |
- |
- |
- |
- |
067 2件: 67, 299 💬 |
52 |
Gz402671 |
- |
- |
- |
- |
019 2件: 19, 67 💬 |
53 |
Hct |
- |
- |
- |
- |
067 1件: 67 💬 |
54 |
High water intake |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
55 |
Hydralazine |
Hydralazine |
2件: D01302 D01302, D08044 D08044 💬 |
AOC3 1件: AOC3 💬 |
Glycine, serine and threonine metabolism 5件: Glycine, serine and threonine metabolism, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, beta-Alanine metabolism |
067 1件: 67 💬 |
56 |
Hydrochlorothiazide |
Hydrochlorothiazide |
1件: D00340 D00340 💬 |
- |
- |
013 4件: 13, 67, 225, 235 💬 |
57 |
Imidapril |
Imidapril |
1件: D08068 D08068 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
067 1件: 67 💬 |
58 |
Intravenous injection autologous mesenchymal stem cells |
- |
- |
- |
- |
067 1件: 67 💬 |
59 |
Iohexol |
Iohexol |
1件: D01817 D01817 💬 |
- |
- |
019 2件: 19, 67 💬 |
60 |
Iohexol inj 300 milligrams per milliliter (mg/ml) |
Iohexol |
1件: D01817 D01817 💬 |
- |
- |
067 1件: 67 💬 |
61 |
Istin |
- |
- |
- |
- |
067 1件: 67 💬 |
62 |
Jinarc |
- |
- |
- |
- |
067 1件: 67 💬 |
63 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
64 |
Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 1件: 67 💬 |
65 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
66 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
67 |
Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 1件: 67 💬 |
68 |
Jinarc - tolvaptan tablets |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
69 |
Jinarc 15 mg tablets, jinarc 45 mg tablets |
- |
- |
- |
- |
067 1件: 67 💬 |
70 |
Jinarc 30 mg tablets, 90 mg tablets |
- |
- |
- |
- |
067 1件: 67 💬 |
71 |
Jinarc 30 mg tablets, jinarc 60 mg tablets |
- |
- |
- |
- |
067 1件: 67 💬 |
72 |
Jinarc® 15mg tablet |
- |
- |
- |
- |
067 1件: 67 💬 |
73 |
Jinarc® 30 tablet |
- |
- |
- |
- |
067 1件: 67 💬 |
74 |
Kd019 (tesevatinib) |
Tesevatinib |
1件: D11772 D11772 💬 |
EGFR 5件: EGFR, EPHB4, ERBB2, FLT4, KDR 💬 |
Adherens junction 51件: Adherens junction, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, VEGF signaling pathway |
067 1件: 67 💬 |
75 |
Lanreotide |
Lanreotide |
1件: D04666 D04666 💬 |
- |
- |
067 4件: 67, 73, 85, 298 💬 |
76 |
Lanreotide acetate |
Acetate |
1件: D04666 D04666 💬 |
- |
- |
067 4件: 67, 73, 85, 298 💬 |
77 |
Lisinopril |
Lisinopril |
2件: D00362 D00362, D08131 D08131 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 49, 66, 67, 113, 222 💬 |
78 |
Lixivaptan |
Lixivaptan |
1件: D04752 D04752 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
79 |
Long-acting somatostatin |
Somatostatin |
1件: D07431 D07431 💬 |
SSTR1 5件: SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 1件: 67 💬 |
80 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
81 |
Metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
82 |
Metformina |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
067 2件: 67, 113 💬 |
83 |
Monocor |
- |
- |
- |
- |
067 1件: 67 💬 |
84 |
Ng-monomethyl-l-arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
067 1件: 67 💬 |
85 |
Ng-monomethyl-l-arginine (drug) |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
067 1件: 67 💬 |
86 |
Niacinamide |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
005 4件: 5 , 6 , 13, 67 💬 |
87 |
Octeotride |
- |
- |
- |
- |
067 1件: 67 💬 |
88 |
Octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 7件: 67, 75, 84, 85, 89, 193, 227 💬 |
89 |
Octreotide lar |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 2件: 67, 227 💬 |
90 |
Octreotide-lar |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 1件: 67 💬 |
91 |
Opc-41061 |
- |
- |
- |
- |
067 1件: 67 💬 |
92 |
Opc-41061 (tolvaptan) |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
93 |
Other: ad libitum water intake |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
94 |
Other: high water intake |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
95 |
Other: low blood pressure control |
- |
- |
- |
- |
067 1件: 67 💬 |
96 |
Other: saline solution |
- |
- |
- |
- |
067 1件: 67 💬 |
97 |
Other: saline solution. |
- |
- |
- |
- |
067 1件: 67 💬 |
98 |
Other: standard |
- |
- |
- |
- |
067 1件: 67 💬 |
99 |
Other: standard blood pressure control |
- |
- |
- |
- |
067 1件: 67 💬 |
100 |
Other: water |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
101 |
Other: water prescription |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
102 |
Pasireotide |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 3件: 67, 74, 75 💬 |
103 |
Pasireotide lar |
Pasireotide |
1件: D10147 D10147 💬 |
SSTR1 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 2件: 67, 75 💬 |
104 |
Pf-05208763 |
- |
- |
- |
- |
067 1件: 67 💬 |
105 |
Pioglitazone |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
106 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
107 |
Potassium |
Potassium |
1件: D08403 D08403 💬 |
- |
- |
036 10件: 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
108 |
Pravastatin |
Pravastatin |
2件: D00893 D00893, D08410 D08410 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
109 |
Procedure: renal sympathetic denervation |
- |
- |
- |
- |
067 1件: 67 💬 |
110 |
Protein |
- |
- |
- |
- |
046 2件: 46, 67 💬 |
111 |
Rad001 |
- |
- |
- |
- |
034 6件: 34, 67, 89, 96, 158, 228 💬 |
112 |
Radiation: pet/ct scan |
- |
- |
- |
- |
067 1件: 67 💬 |
113 |
Ramipril |
Ramipril |
1件: D00421 D00421 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 7件: 46, 49, 66, 67, 113, 218, 257 💬 |
114 |
Rapamune |
- |
- |
- |
- |
002 8件: 2 , 60, 66, 67, 84, 158, 278, 280 💬 |
115 |
Rapamune 1mg tablets |
- |
- |
- |
- |
067 1件: 67 💬 |
116 |
Rapamune*100cpr riv 1mg |
- |
- |
- |
- |
067 1件: 67 💬 |
117 |
Rapamune*30cpr riv 1mg |
- |
- |
- |
- |
067 1件: 67 💬 |
118 |
Rapamune*30cpr riv 2mg |
- |
- |
- |
- |
067 1件: 67 💬 |
119 |
Rapamycin |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 18件: 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
120 |
Rgls4326 |
- |
- |
- |
- |
067 1件: 67 💬 |
121 |
Rta 402 |
- |
- |
- |
- |
067 3件: 67, 86, 218 💬 |
122 |
Saline |
- |
- |
- |
- |
006 10件: 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
123 |
Samsca |
- |
- |
- |
- |
067 2件: 67, 72 💬 |
124 |
Samsca 15 mg tablets |
- |
- |
- |
- |
067 1件: 67 💬 |
125 |
Samsca 30 mg tablets |
- |
- |
- |
- |
067 1件: 67 💬 |
126 |
Sandostatin lar |
- |
- |
- |
- |
067 4件: 67, 84, 193, 227 💬 |
127 |
Sandostatina |
- |
- |
- |
- |
067 1件: 67 💬 |
128 |
Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi |
- |
- |
- |
- |
067 1件: 67 💬 |
129 |
Sandostatina lar |
- |
- |
- |
- |
067 1件: 67 💬 |
130 |
Sandostatina lar im fl 20mg +2f |
- |
- |
- |
- |
067 1件: 67 💬 |
131 |
Sar402671, gz402671 or gz/sar402671 |
- |
- |
- |
- |
006 3件: 6 , 19, 67 💬 |
132 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
133 |
Ski-606 |
- |
- |
- |
- |
067 1件: 67 💬 |
134 |
Sodium citrate |
Sodium citrate |
2件: D01781 D01781, D05855 D05855 💬 |
- |
- |
067 4件: 67, 214, 215, 235 💬 |
135 |
Sodiumchloride |
- |
- |
- |
- |
067 1件: 67 💬 |
136 |
Somatostatin |
Somatostatin |
1件: D07431 D07431 💬 |
SSTR1 5件: SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 2件: 67, 78 💬 |
137 |
Somatuline |
- |
- |
- |
- |
067 2件: 67, 298 💬 |
138 |
Somatuline autogel |
- |
- |
- |
- |
067 1件: 67 💬 |
139 |
Somatuline autosolution |
- |
- |
- |
- |
067 1件: 67 💬 |
140 |
Spironolactone |
Spironolactone |
1件: D00443 D00443 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
058 7件: 58, 67, 86, 113, 210, 218, 225 💬 |
141 |
Sugar pill |
- |
- |
- |
- |
005 8件: 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
142 |
Telmisartan |
Telmisartan |
1件: D00627 D00627 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 2件: 66, 67 💬 |
143 |
Tesevatinib |
Tesevatinib |
1件: D11772 D11772 💬 |
EGFR 5件: EGFR, EPHB4, ERBB2, FLT4, KDR 💬 |
Adherens junction 51件: Adherens junction, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, VEGF signaling pathway |
067 1件: 67 💬 |
144 |
Tetracosactin |
- |
- |
- |
- |
067 1件: 67 💬 |
145 |
Tolvaptan |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 3件: 67, 72, 225 💬 |
146 |
Tolvaptan (opc-41061) |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
147 |
Tolvaptan 15 |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
148 |
Tolvaptan 15 mg tablet |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
149 |
Tolvaptan 15 mg tablets |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
150 |
Tolvaptan 15mg |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
151 |
Tolvaptan 30 |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
152 |
Tolvaptan 30 mg tablet |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
153 |
Tolvaptan 30 mg tablets |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
154 |
Tolvaptan 30mg |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
155 |
Tolvaptan 45/15 |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
156 |
Tolvaptan 60/30 |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
157 |
Tolvaptan 7.5 mg tablet |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
158 |
Tolvaptan ir |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
159 |
Tolvaptan mr |
Tolvaptan |
1件: D01213 D01213 💬 |
AVPR2 1件: AVPR2 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 1件: 67 💬 |
160 |
Tripterygium |
Tripterygium wilfordii whole |
- |
- |
- |
046 8件: 46, 66, 67, 96, 162, 222, 224, 271 💬 |
161 |
Tripterygium wilfordii |
Tripterygium wilfordii whole |
- |
- |
- |
046 6件: 46, 66, 67, 222, 224, 271 💬 |
162 |
Triptolide |
Triptolide |
- |
- |
- |
067 1件: 67 💬 |
163 |
Triptolide-containing formulation |
Triptolide |
- |
- |
- |
067 1件: 67 💬 |
164 |
Udca |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
067 5件: 67, 93, 94, 97, 296 💬 |
165 |
Unknown |
- |
- |
- |
- |
067 2件: 67, 97 💬 |
166 |
Ursochol |
- |
- |
- |
- |
067 1件: 67 💬 |
167 |
Ursochol 300 |
- |
- |
- |
- |
067 1件: 67 💬 |
168 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
006 8件: 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
169 |
Venglustat |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
006 3件: 6 , 19, 67 💬 |
170 |
Venglustat gz/sar402671 |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
067 1件: 67 💬 |
171 |
Venglustat gz402671 |
Venglustat |
1件: D11633 D11633 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
019 2件: 19, 67 💬 |
172 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
173 |
Zestril |
- |
- |
- |
- |
019 3件: 19, 67, 222 💬 |
174 |
Zuglimet - 500 mg compresse rivestite con film 30 compresse in blister pvc/al |
- |
- |
- |
- |
067 1件: 67 💬 |